{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T14:07:24Z","timestamp":1790086044466,"version":"4.0.1"},"reference-count":27,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:00:00Z","timestamp":1790035200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Sleep is crucial for the clearance of metabolic waste products. Sleep deprivation leads to the accumulation of amyloid-\n                      <jats:italic>\u03b2<\/jats:italic>\n                      (A\u03b2) and tau proteins, which may be mediated by impaired glymphatic clearance, thereby contributing to the hallmark pathologies of Alzheimer\u2019s disease (AD). The apolipoprotein E (APOE) gene, particularly the\n                      <jats:italic>APOE<\/jats:italic>\n                      \u03b54 allele, is a major genetic risk factor for AD and is also closely associated with sleep. Notably, the interaction between poor sleep and APOE \u03b54 may further enhance AD risk. However, prior studies have reported inconsistent effects of sleep deprivation on AD related biomarkers, and clinical studies stratified by\n                      <jats:italic>APOE<\/jats:italic>\n                      genotype are lacking. This study aims to investigate the effects of 24-h acute sleep deprivation on plasma AD biomarkers and to assess\n                      <jats:italic>APOE<\/jats:italic>\n                      genotype-dependent responses.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      This prospective, randomized open-label, blinded-endpoint trial plans to enroll 60 healthy young adults. Participants will be stratified by\n                      <jats:italic>APOE<\/jats:italic>\n                      genotype into three groups at a 1:1:1 ratio:\n                      <jats:italic>APOE<\/jats:italic>\n                      \u03b53\/\u03b53 homozygotes,\n                      <jats:italic>APOE<\/jats:italic>\n                      \u03b54 carriers (\u03b53\/\u03b54 and \u03b54\/\u03b54 genotypes), and\n                      <jats:italic>APOE<\/jats:italic>\n                      \u03b52 carriers (\u03b52\/\u03b53 and \u03b52\/\u03b52 genotypes). Within each genotype stratum, participants will be randomly assigned in a 1:1 ratio to either the 24-h acute sleep deprivation group or the normal sleep group. The primary outcome is the change in plasma A\u03b2\n                      <jats:sub>42<\/jats:sub>\n                      levels from baseline to day 1 after randomization. Secondary outcomes include changes from baseline to day 1 after randomization in plasma levels of the following biomarkers: A\u03b2\n                      <jats:sub>40<\/jats:sub>\n                      , total tau (t-tau), phosphorylated tau-181 (p-tau181), phosphorylated tau-217 (p-tau217), neurofilament light chain (NfL), and glial fibrillary acidic protein (GFAP). Additionally, the following ratios will be assessed: A\u03b2\n                      <jats:sub>42<\/jats:sub>\n                      \/A\u03b2\n                      <jats:sub>40<\/jats:sub>\n                      , t-tau\/A\u03b2\n                      <jats:sub>42<\/jats:sub>\n                      , p-tau181\/A\u03b2\n                      <jats:sub>42<\/jats:sub>\n                      , and p-tau217\/A\u03b2\n                      <jats:sub>42<\/jats:sub>\n                      . Changes in neuropsychiatric and cognitive assessment will also be evaluated, including scores on the Fatigue Scale-14 (FS-14), the Positive and Negative Affect Schedule (PANAS), and performance on the N-back tasks. Exploratory outcomes include changes in plasma proteomics and metabolomics, as well as positron emission tomography\/magnetic resonance imaging (PET\/MRI) measures.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>\n                      This study serves as the first randomized controlled trial (RCT) to explore the potential influence of acute sleep deprivation on plasma AD biomarkers across different\n                      <jats:italic>APOE<\/jats:italic>\n                      genotypes, with the largest sample size among current RCTs on sleep deprivation. This trial is expected to generate critical evidence elucidating the impact of 24-h acute sleep deprivation on the pathophysiology of AD and to inform the development of future sleep-focused preventive interventions.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Study protocol registration<\/jats:title>\n                    <jats:p>\n                      <jats:uri>ClinicalTrials.gov<\/jats:uri>\n                      , identifier NCT07085754.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fneur.2026.1805467","type":"journal-article","created":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T13:52:37Z","timestamp":1790085157000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Effects of acute sleep deprivation on individuals across different APOE genotypes: a randomized controlled trial protocol"],"prefix":"10.3389","volume":"17","author":[{"given":"He-Jin","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Neurology, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine","place":["Guangzhou, Guangdong, China"]},{"name":"Department of Neurology, Guangdong Provincial Hospital of Chinese Medicine","place":["Guangzhou, Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling-Ling","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Neurology, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine","place":["Guangzhou, Guangdong, China"]},{"name":"Department of Neurology, Guangdong Provincial Hospital of Chinese Medicine","place":["Guangzhou, Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Hang","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Neurology, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine","place":["Guangzhou, Guangdong, China"]},{"name":"Department of Neurology, Guangdong Provincial Hospital of Chinese Medicine","place":["Guangzhou, Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Hui","family":"Qiu","sequence":"additional","affiliation":[{"name":"Department of Neurology, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine","place":["Guangzhou, Guangdong, China"]},{"name":"Department of Neurology, Guangdong Provincial Hospital of Chinese Medicine","place":["Guangzhou, Guangdong, China"]},{"name":"State Key Laboratory of Traditional Chinese Medicine Syndrome, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine","place":["Guangzhou, Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Xia","sequence":"additional","affiliation":[{"name":"Department of Neurology, Beijing Tiantan Hospital, Capital Medical University","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye-Feng","family":"Cai","sequence":"additional","affiliation":[{"name":"Department of Neurology, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine","place":["Guangzhou, Guangdong, China"]},{"name":"Department of Neurology, Guangdong Provincial Hospital of Chinese Medicine","place":["Guangzhou, Guangdong, China"]},{"name":"State Key Laboratory of Traditional Chinese Medicine Syndrome, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine","place":["Guangzhou, Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-Jie","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Neurology, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine","place":["Guangzhou, Guangdong, China"]},{"name":"Department of Neurology, Guangdong Provincial Hospital of Chinese Medicine","place":["Guangzhou, Guangdong, China"]},{"name":"State Key Laboratory of Traditional Chinese Medicine Syndrome, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine","place":["Guangzhou, Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,22]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"e2504961122","DOI":"10.1073\/pnas.2504961122","article-title":"Neurofluid circulation changes during a focused attention style of mindfulness meditation","volume":"122","author":"Keating","year":"2025","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"e28819","DOI":"10.1016\/j.heliyon.2024.e28819","article-title":"Sleep deprivation: a risk factor for the pathogenesis and progression of Alzheimer's disease","volume":"10","author":"Han","year":"2024","journal-title":"Heliyon"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1126\/science.1241224","article-title":"Sleep drives metabolite clearance from the adult brain","volume":"342","author":"Xie","year":"2013","journal-title":"Science"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1126\/science.aav2546","article-title":"The sleep-wake cycle regulates brain interstitial fluid tau in mice and CSF tau in humans","volume":"363","author":"Holth","year":"2019","journal-title":"Science"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1038\/d41586-018-05717-6","article-title":"Alzheimer's disease","volume":"559","author":"Hodson","year":"2018","journal-title":"Nature"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"102457","DOI":"10.1016\/j.arr.2024.102457","article-title":"Mechanisms, consequences and role of interventions for sleep deprivation: focus on mild cognitive impairment and Alzheimer's disease in elderly","volume":"100","author":"Mukherjee","year":"2024","journal-title":"Ageing Res Rev"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"137","DOI":"10.15585\/mmwr.mm6506a1","article-title":"Prevalence of healthy sleep duration among adults--United States, 2014","volume":"65","author":"Liu","year":"","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1164\/rccm.1996P11","article-title":"What is sleep deprivation?","volume":"199","author":"Bandyopadhyay","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.1038\/s41467-021-22354-2","article-title":"Association of sleep duration in middle and old age with incidence of dementia","volume":"12","author":"Sabia","year":"2021","journal-title":"Nat Commun"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"4483","DOI":"10.1073\/pnas.1721694115","article-title":"\u0392-Amyloid accumulation in the human brain after one night of sleep deprivation","volume":"115","author":"Shokri-Kojori","year":"2018","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"3055","DOI":"10.1002\/alz.12930","article-title":"Acute sleep loss decreases CSF-to-blood clearance of Alzheimer's disease biomarkers","volume":"19","author":"Liu","year":"2023","journal-title":"Alzheimers Dement"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"e1647","DOI":"10.1212\/wnl.0000000000008081","article-title":"High-precision plasma \u03b2-amyloid 42\/40 predicts current and future brain amyloidosis","volume":"93","author":"Schindler","year":"2019","journal-title":"Neurology"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/0306-4522(95)00331-c","article-title":"Influence of the apolipoprotein E genotype on amyloid deposition and neurofibrillary tangle formation in Alzheimer's disease","volume":"69","author":"Nagy","year":"1995","journal-title":"Neuroscience"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1212\/WNL.0b013e3181a2e87d","article-title":"Neuropathologic intermediate phenotypes enhance association to Alzheimer susceptibility alleles","volume":"72","author":"Bennett","year":"2009","journal-title":"Neurology"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1002\/ana.24369","article-title":"APOE\u03b52 is associated with milder clinical and pathological Alzheimer disease","volume":"77","author":"Serrano-Pozo","year":"2015","journal-title":"Ann Neurol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/s41467-019-14279-8","article-title":"Exceptionally low likelihood of Alzheimer's dementia in APOE2 homozygotes from a 5, 000-person neuropathological study","volume":"11","author":"Reiman","year":"2020","journal-title":"Nat Commun"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1001\/jama.2015.4668","article-title":"Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis","volume":"313","author":"Jansen","year":"2015","journal-title":"JAMA"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1038\/s41591-024-02931-w","article-title":"APOE4 homozygosity represents a distinct genetic form of Alzheimer\u2019s disease","volume":"30","author":"Fortea","year":"2024","journal-title":"Nat Med"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1212\/wnl.0000000000003255","article-title":"Evidence of association between sleep quality and APOE \u03b54 in healthy older adults: a pilot study","volume":"87","author":"Drogos","year":"2016","journal-title":"Neurology"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1097\/YPG.0b013e32834dc438","article-title":"The role of PGC-1 and Apo\u03b5 4 in insomnia","volume":"22","author":"Wang","year":"2012","journal-title":"Psychiatr Genet"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1212\/01.wnl.0000134671.99649.32","article-title":"APOE epsilon 4 is associated with obstructive sleep apnea\/hypopnea: the sleep heart health study","volume":"63","author":"Gottlieb","year":"2004","journal-title":"Neurology"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"2888","DOI":"10.1001\/jama.285.22.2888","article-title":"Association between apolipoprotein E epsilon 4 and sleep-disordered breathing in adults","volume":"285","author":"Kadotani","year":"2001","journal-title":"JAMA"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"9131","DOI":"10.1172\/JCI169131","article-title":"APOE-\u03b54 synergizes with sleep disruption to accelerate a\u03b2 deposition and a\u03b2-associated tau seeding and spreading","volume":"133","author":"Wang","year":"2023","journal-title":"J Clin Invest"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/0022-3999(93)90081-p","article-title":"Development of a fatigue scale","volume":"37","author":"Chalder","year":"1993","journal-title":"J Psychosom Res"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.jpsychores.2009.05.008","article-title":"Construct validity of the Chinese version of the Chalder fatigue scale in a Chinese community sample","volume":"68","author":"Wong","year":"2010","journal-title":"J Psychosom Res"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1037\/\/0022-3514.54.6.1063","article-title":"Development and validation of brief measures of positive and negative affect: the PANAS scales","volume":"54","author":"Watson","year":"1988","journal-title":"J Pers Soc Psychol"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1037\/0278-7393.33.3.615","article-title":"Working memory, attention control, and the N-back task: a question of construct validity","volume":"33","author":"Kane","year":"2007","journal-title":"J Exp Psychol Learn Mem Cogn"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2026.1805467\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T13:52:38Z","timestamp":1790085158000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2026.1805467\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,22]]},"references-count":27,"alternative-id":["10.3389\/fneur.2026.1805467"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2026.1805467","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,22]]},"article-number":"1805467"}}